aTyr Pharma, Inc. Common Stock

ATYRNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
6.11 USD
↘ 0.10 (1.69%)AT CLOSE (03:59 PM EST)
6.17
↗ 0.07 (1.11%)
POST MARKET (AS OF 04:13 PM EST)
Post Market
AS OF 04:13 PM EST
6.17
↗ 0.07 (1.11%)
🔴Market: CLOSED

aTyr Pharma, Inc. Common Stock (ATYR) is currently trading at $6.11. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place ATYR at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$6.24
High?$6.54
Low?$5.96
Prev. Close?$6.21
Volume?38.1K
Avg. Volume?1.4M
VWAP?$6.28
Rel. Volume?0.03x
Bid / Ask
Bid?$6.00 × 100
Ask?$6.35 × 100
Spread?$0.35
Midpoint?$6.18
Valuation & Ratios
Market Cap?15.6M
Shares Out?N/A
Float?97.8M
Float %?99.7%
P/E Ratio?N/A
P/B Ratio?0.32
EPS?-$23.85
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
Themes
Biotech - Drug Development›Rare Disease Therapeutics
Employees
58
Market Cap
15.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.atyrpharma.com
Listed
2015-05-07
Address
10240 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
Phone: (858) 731-8389
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
68
Piotroski F-Score?0/9Weak
Altman Z-Score?-13.97Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?0.30%Low
Short Interest?293.4K
Days to Cover?3.4
Free Float97.8M
Avg Daily Volume87.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?5.12Strong
Quick Ratio?5.12Strong
Cash Ratio?1.42Strong
Debt/Equity?0.01Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.32CHEAP▾
P/S?
Peers
100
S&P
3
81.98HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
0.0CHEAP▾
EV/Sales?
S&P
97
-0.16CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-124.6%WEAK▾
ROA?
S&P
3
-87.1%WEAK▾
Cash Flow & Enterprise
FCF?$-54819000
Enterprise Value?$-30205
Fundamentals ratios updated end of day
MarketsMoversWatchlist